BTAI stock – Knox Daily

Analysts Viewpoint

BioXcel Therapeutics Inc’s filing revealed that its Chief Scientific Officer Yocca Frank unloaded Company’s shares for reported $476.0 on Jun

Stock Earnings

BioXcel Therapeutics Inc’s filing revealed that its Chief Scientific Officer Yocca Frank unloaded Company’s shares for reported $476.0 on Jun

Insiders Updates

BioXcel Therapeutics Inc’s recent filing unveils that its Chief Scientific Officer Yocca Frank unloaded Company’s shares for reported $476.0 on

Analysts Viewpoint

Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. BioXcel Therapeutics

Insiders Updates

BioXcel Therapeutics Inc’s recently made public that its CEO and President Mehta Vimal unloaded Company’s shares for reported $2739.0 on

Stock Earnings

BioXcel Therapeutics Inc’s recently made public that its CEO and President Mehta Vimal unloaded Company’s shares for reported $2739.0 on

Insiders Updates

Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its

Stock Earnings

BioXcel Therapeutics Inc’s recently made public that its CEO and President Mehta Vimal unloaded Company’s shares for reported $2739.0 on

News

BioXcel Therapeutics, Inc. (NASDAQ: BTAI) observed a substantial increase in its stock value, rising by 26.02% in the prior trading

Tag: BTAI stock